WallStSmart
TERN

Terns Pharmaceuticals Inc

NASDAQ: TERN · HEALTHCARE · BIOTECHNOLOGY

$52.92
-0.04% today

Updated 2026-04-29

Market cap
$6.11B
P/E ratio
P/S ratio
302.64x
EPS (TTM)
$-1.03
Dividend yield
52W range
$3 – $53
Volume
6.6M

Terns Pharmaceuticals Inc (TERN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+13.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+7.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+2.4%
Last 4 reports
Positive reaction rate
25%
1 of 4 quarters
Largest single-day move
+11.4%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.24$52.88$52.79-0.2%
2026-03-31$-0.24+20.0%$52.88$52.79-0.2%
2025-11-10$-0.27+10.6%$18.47$20.58+11.4%
2025-08-05$-0.26+10.9%$5.75$5.67-1.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.24
2025-12-31$-0.30$-0.24+20.0%
2025-09-30$-0.30$-0.27+10.6%
2025-06-30$-0.29$-0.26+10.9%
2025-03-31$-0.27$-0.26+3.8%
2024-12-31$-0.30$-0.24+20.1%
2024-09-30$-0.32$-0.28+12.5%
2024-06-30$-0.34$-0.31+8.8%
2024-03-31$-0.34$-0.30+11.8%
2023-12-31$-0.29$-0.29+0.0%$1.32M
2023-09-30$-0.31$-0.42-35.5%

Frequently asked questions

Has Terns Pharmaceuticals Inc beaten earnings estimates?
Terns Pharmaceuticals Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +13.8% over the last 3 quarters.
How does TERN stock react to earnings?
TERN stock has moved an average of +2.4% in the trading day following earnings over its last 4 reports, with positive reactions in 25% of those quarters.